Related Experiment Videos

Continuous quality improvement: improving hemodialysis catheter patency using urokinase

C Northsea1

  • 1Hemodialysis unit, Department of Veterans Affairs Medical Center, Gainesville, FL, USA.

ANNA Journal
|December 1, 1996
PubMed

Insights

Continuous quality improvement (CQI) programs can enhance patient outcomes. A 2-year CQI program using urokinase successfully improved dialysis catheter patency rates, benefiting patients, staff, and program costs.

Area of Science:

  • Nephrology
  • Vascular Access
  • Quality Improvement

Background:

  • Vascular access outcomes remain a significant challenge for hemodialysis patients.
  • Dialysis catheters are increasingly used as permanent vascular access, posing a risk of catheter occlusion.
  • Catheter occlusion is a common complication affecting hemodialysis treatment efficacy.

Purpose of the Study:

  • To implement and evaluate a 2-year continuous quality improvement (CQI) program.
  • To improve dialysis catheter patency rates in hemodialysis patients.
  • To assess the clinical, staff, and cost-effectiveness of the CQI program.

Main Methods:

  • Development and implementation of a 2-year CQI program.
  • Utilized urokinase to address dialysis catheter occlusion.
  • Monitored clinical outcomes, patient and staff benefits, and cost-effectiveness.

Main Results:

  • The CQI program demonstrated significant improvements in dialysis catheter patency.
  • Observed beneficial clinical outcomes for hemodialysis patients.
  • Reported positive impacts on dialysis staff and cost-effectiveness.

Conclusions:

  • Applied CQI programs offer substantial opportunities for improving patient outcomes in nephrology.
  • The implemented CQI program effectively enhanced dialysis catheter patency.
  • The use of urokinase within a CQI framework proved beneficial and cost-effective.

Related Concept Videos